Search research articles
Contact Us
Filters
Showing results (41-50 of 46) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 46 results.
ACS Medicinal Chemistry Letters
|
January 19, 2011
Evaluation of Diarylureas for Activity Against Plasmodium falciparum
Yiqun Zhang, Marc Anderson, Jennifer L Weisman, et al.
Malaria Journal
|
May 12, 2016
Diversity-oriented natural product platform identifies plant constituents targeting Plasmodium falciparum
Jin Zhang, John J Bowling, David Smithson, et al.
Lancet (London, England)
|
September 11, 2023
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial
Arshad M Khanani, Sunil S Patel, Giovanni Staurenghi, et al.
Experimental Eye Research
|
May 7, 2022
Artificial intelligence-based strategies to identify patient populations and advance analysis in age-related macular degeneration clinical trials
Antonio Yaghy, Aaron Y Lee, Pearse A Keane, et al.
Nature
|
May 21, 2010
Chemical genetics of Plasmodium falciparum
W Armand Guiguemde, Anang A Shelat, David Bouck, et al.
ACS Central Science
|
November 2, 2016
Open Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos Arylpyrroles
Alice E Williamson, Paul M Ylioja, Murray N Robertson, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 46) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 46 results.
ACS Medicinal Chemistry Letters
|
January 19, 2011
Evaluation of Diarylureas for Activity Against Plasmodium falciparum
Yiqun Zhang, Marc Anderson, Jennifer L Weisman, et al.
Malaria Journal
|
May 12, 2016
Diversity-oriented natural product platform identifies plant constituents targeting Plasmodium falciparum
Jin Zhang, John J Bowling, David Smithson, et al.
Lancet (London, England)
|
September 11, 2023
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial
Arshad M Khanani, Sunil S Patel, Giovanni Staurenghi, et al.
Experimental Eye Research
|
May 7, 2022
Artificial intelligence-based strategies to identify patient populations and advance analysis in age-related macular degeneration clinical trials
Antonio Yaghy, Aaron Y Lee, Pearse A Keane, et al.
Nature
|
May 21, 2010
Chemical genetics of Plasmodium falciparum
W Armand Guiguemde, Anang A Shelat, David Bouck, et al.
ACS Central Science
|
November 2, 2016
Open Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos Arylpyrroles
Alice E Williamson, Paul M Ylioja, Murray N Robertson, et al.
Page
of 5